Alzheimer's disease
| 3 min read
Activating specific neurons using light helped scientists establish a causal link between improved sleep and diminished signs of Alzheimer’s disease in mice.
Available on Demand
Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.
| 3 min read
A small molecule called ALGERNON2 improved health outcomes in mouse models of neurodegenerative diseases by activating antioxidant pathways in astrocytes.
| 2 min read
A dementia-associated tau mutation promotes unusual clustering of Fyn, a protein important for learning and memory.
| 4 min read
A collaboration of nephrologists and biochemists created the first structure of “megalin,” a critical protein in kidney and brain disorders.
| 4 min read
By analyzing the changing genomes of short- and long-lived rockfish, scientists identified a new set of genes that might alter lifespan.
| 10+ min read
Drugs that target senescent cells could one day treat frailty, Alzheimer’s disease, or cancer.
| 9 min read
The Alzheimer's disease research field has been beset by failed clinical trials and fraud. But researchers remain hopeful that a better understanding of the disease’s broader picture will lead to treatments.
| 2 min read
Accuracy doesn’t only apply to isolated facts, but to the overall picture they paint.
| 9 min read
Exercise-induced molecules may inspire the next generation of neuroprotective drugs.
